Page 1 of Clinical Trials for Chronic Myeloproliferative Disorders, 967 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Last Updated: May 20, 2010
Condition(s): Polycythemia Vera; Essential Thrombocytosis; Idiopathic Myelofibrosis; Neutrophils; Chronic Myeloproliferative Disorders
2
Recruiting
Research Study in Healthy Volunteers or Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
Last Updated: September 6, 2011
Condition(s): Chronic Myeloproliferative Disorders; Fanconi Anemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic/Myeloproliferative Neoplasms
3
Recruiting
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
Last Updated: April 9, 2010
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
4
Completed
Decitabine and FR901228 in Treating Patients With Relapsed or Refractory Leukemia, Myelodysplastic Syndromes, or Myeloproliferative Disorders
Last Updated: June 4, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
5
Recruiting
T-cell Recovery in Patients With Leukemia, Advanced Lymphoma, Myelodysplastic Syndrome, or Myeloproliferative Disorder Receiving Alemtuzumab and Undergoing Donor Stem Cell Transplant
Last Updated: May 12, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
6
Completed
Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
Last Updated: March 29, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia
7
Completed
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Last Updated: May 16, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
8
Completed
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Last Updated: May 12, 2010
Condition(s): Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
9
Recruiting
INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Last Updated: January 18, 2012
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unspecified Childhood Solid Tumor, Protocol Specific
10
Recruiting
ABT-888 and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
Last Updated: January 25, 2012
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes
11
Completed
3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia
Last Updated: August 5, 2011
Condition(s): Chronic Myeloproliferative Disorders; Leukemia
12
Active, not recruiting
Low-Dose Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Allogeneic Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Chronic Myelogenous Leukemia
Last Updated: February 20, 2010
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes
13
Active, not recruiting
Tipifarnib in Treating Patients With Myeloproliferative Disorders
Last Updated: June 4, 2011
Condition(s): Leukemia; Myelodysplastic/Myeloproliferative Neoplasms
14
Recruiting
JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders
Last Updated: June 23, 2011
Condition(s): Myeloproliferative Disorders
15
Completed
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Last Updated: August 25, 2011
Condition(s): Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
16
Withdrawn
Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder
Last Updated: January 30, 2009
Condition(s): Leukemia
17
Recruiting
Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
Last Updated: November 22, 2011
Condition(s): Myeloproliferative Neoplasms
18
Recruiting
Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
Last Updated: October 7, 2011
Condition(s): Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Childhood Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Paroxysmal Nocturnal Hemoglobinuria; Philadelphia Chromosome Negative Chronic Myelogenous Leukemia; Polycythemia Vera; Primary Myelofibrosis; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ringed Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis
19
Completed
Non-Myeloablative Allogeneic Transplant for Myelodysplastic Syndromes and Myeloproliferative Disorders
Last Updated: October 13, 2010
Condition(s): Myelodysplastic Syndromes; Myeloproliferative Disorders; Blood and Marrow Transplant (BMT); Myelodysplastic Syndromes (MDS); Myeloproliferative Disorders (MPD)
20
Recruiting
A Study in Myeloproliferative Disorders
Last Updated: September 6, 2011
Condition(s): Myeloproliferative Disorders; Thrombocythemia, Essential; Polycythemia Vera; Primary Myelofibrosis

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Chronic+Myeloproliferative+Disorders

Page 1 of Clinical Trials for Chronic Myeloproliferative Disorders, 967 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About